Evidence map›Paper›PMID 33381811›Full record

ArticleBioinformatics (Oxford, England)2020

Enhancing statistical power in temporal biomarker discovery through representative shapelet mining.

Thomas Gumbsch, Christian Bock, Michael Moor, Bastian Rieck, Karsten Borgwardt

Open access · hybridAbstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Thomas GumbschDepartment of Biosystems Science and Engineering, ETH Zurich, Basel 4058, Switzerland.
Christian BockDepartment of Biosystems Science and Engineering, ETH Zurich, Basel 4058, Switzerland.
Michael MoorDepartment of Biosystems Science and Engineering, ETH Zurich, Basel 4058, Switzerland.
Bastian RieckDepartment of Biosystems Science and Engineering, ETH Zurich, Basel 4058, Switzerland.
Karsten BorgwardtDepartment of Biosystems Science and Engineering, ETH Zurich, Basel 4058, Switzerland.
ETH Zurich · CHSIB Swiss Institute of Bioinformatics · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

motivationTemporal biomarker discovery in longitudinal data is based on detecting reoccurring trajectories, the so-called shapelets. The search for shapelets requires considering all subsequences in the data. While the accompanying issue of multiple testing has been mitigated in previous work, the redundancy and overlap of the detected shapelets results in an a priori unbounded number of highly similar and structurally meaningless shapelets. As a consequence, current temporal biomarker discovery methods are impractical and underpowered.

resultsWe find that the pre- or post-processing of shapelets does not sufficiently increase the power and practical utility. Consequently, we present a novel method for temporal biomarker discovery: Statistically Significant Submodular Subset Shapelet Mining (S5M) that retrieves short subsequences that are (i) occurring in the data, (ii) are statistically significantly associated with the phenotype and (iii) are of manageable quantity while maximizing structural diversity. Structural diversity is achieved by pruning non-representative shapelets via submodular optimization. This increases the statistical power and utility of S5M compared to state-of-the-art approaches on simulated and real-world datasets. For patients admitted to the intensive care unit (ICU) showing signs of severe organ failure, we find temporal patterns in the sequential organ failure assessment score that are associated with in-ICU mortality. AVAILABILITY AND IMPLEMENTATION: S5M is an option in the python package of S3M: github.com/BorgwardtLab/S3M.

Indexed as

Biomedical ResearchBiomarkersHumansPhenotypeResearch DesignBiomarkers

Identifiers

PMID33381811
PMCPMC7773478
OpenAlexW3113760670

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.